Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Advances in hepatitis B and C.

Emma C Thomson1, Janice Main

  • 1St Mary's Hospital, Praed Street, London W2 1NY, UK.

Current Opinion in Infectious Diseases
|September 9, 2004
PubMed
Summary

New treatments for hepatitis B and C are emerging, focusing on patients with difficult-to-treat infections or co-morbidities. Research highlights include prolonged therapy for hepatitis C and new options like adefovir for hepatitis B.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Contaminating plasmid sequences and disrupted vector genomes in the liver following adeno-associated virus gene therapy.

Nature medicine·2026
Same author

Causes, associated exposures, and outcomes of cirrhosis and hepatocellular carcinoma in Malawi: an observational cohort and case-control study.

The Lancet. Global health·2025
Same author

Heterologous COVID-19 vaccine schedule with protein-based prime (NVX-CoV2373) and mRNA boost (BNT162b2) induces strong humoral responses: Results from COV-BOOST trial.

The Journal of infection·2025
Same author

Retrovirus-based pseudotyped virus neutralisation assays overestimate neutralising activity in sera from participants receiving integrase inhibitors.

Scientific reports·2025
Same author

Estimating population immunity to SARS-CoV-2 by random sampling from primary and secondary healthcare in Scotland, May 2024.

EBioMedicine·2025
Same author

Uncovering the viral aetiology of undiagnosed acute febrile illness in Uganda using metagenomic sequencing.

Nature communications·2025

Area of Science:

  • Hepatology
  • Infectious Diseases
  • Virology

Background:

  • Hepatitis B and C are global health issues causing significant liver damage.
  • Chronic infections lead to severe complications like fibrosis, cirrhosis, and cancer.
  • New therapeutic strategies are crucial for non-responders and patients with comorbidities.

Purpose of the Study:

  • To review recent literature on hepatitis B and C.
  • Focus on novel treatment options.
  • Examine approaches for treatment-failure and co-morbid patients.

Main Methods:

  • Literature review of recent studies.
  • Analysis of treatment efficacy in specific patient cohorts.
  • Synthesis of data on emerging therapies.

Main Results:

  • Prolonged treatment benefits hepatitis C genotype 1.
  • Pegylated interferon is valuable for chronic hepatitis B.
  • Adefovir shows promise for resistant hepatitis B.
  • Co-infection with HIV is a focus of treatment.
  • Special attention given to transplant and immunosuppressed patients.

Conclusions:

  • Hepatitis B and C research is rapidly advancing.
  • Emerging treatments are increasingly tailored to specific patient groups.
  • Personalized therapeutic approaches are key.

Related Experiment Videos